About FDA
Number of Commercial Investigational New Drugs Applications (INDs)/Investigational Drug Exemptions (IDEs) received in the month (1)
Dictionary: This measure shows the number of commercial, research, and emergency INDs / IDEs received in the month. An IND / IDE application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs / IDEs reflect new products under development. Research INDs / IDEs reflect work that supports research and public health initiatives. Emergency INDs are requests to FDA, generally made by telephone, for an investigational drug to be used for the treatment of an individual patient by a licensed physician.
Information is current as of September 30, 2012
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 5 |
| Nov 2011 | N/A | 8 |
| Dec 2011 | N/A | 15 |
| Jan 2012 | N/A | 12 |
| Feb 2012 | N/A | 10 |
| Mar 2012 | N/A | 10 |
| Apr 2012 | N/A | 7 |
| May 2012 | N/A | 7 |
| Jun 2012 | N/A | 6 |
| Jul 2012 | N/A | 10 |
| Aug 2012 | N/A | 5 |
| Sep 2012 | N/A | 7 |
FY 2012 Total: 104
Footnotes
- (1) Tracking against these measures did not start until July 2010
Number of Research IND/IDEs received in the month (1)
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 20 |
| Nov 2011 | N/A | 16 |
| Dec 2011 | N/A | 13 |
| Jan 2012 | N/A | 13 |
| Feb 2012 | N/A | 13 |
| Mar 2012 | N/A | 10 |
| Apr 2012 | N/A | 17 |
| May 2012 | N/A | 14 |
| Jun 2012 | N/A | 18 |
| Jul 2012 | N/A | 17 |
| Aug 2012 | N/A | 17 |
| Sep 2012 | N/A | 9 |
FY 2012 Total: 187
Number of Emergency IND/IDEs received in the month (1)
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 2 |
| Nov 2011 | N/A | 2 |
| Dec 2011 | N/A | 1 |
| Jan 2012 | N/A | 1 |
| Feb 2012 | N/A | 1 |
| Mar 2012 | N/A | 4 |
| Apr 2012 | N/A | 3 |
| May 2012 | N/A | 3 |
| Jun 2012 | N/A | 5 |
| Jul 2012 | N/A | 3 |
| Aug 2012 | N/A | 3 |
| Sep 2012 | N/A | 5 |
FY 2012 Total: 35
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
